Germany Veterinary Healthcare Market - Growth, Trends, and Forecasts (2020 - 2025)

The Germany Veterinary Healthcare Market is segmented by Product (Therapeutics, and Diagnostics), and Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals).

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Certain factors that are driving the veterinary healthcare market growth in Germany include advanced technology leading to innovations in animal healthcare, raising awareness, and initiatives by the government, and increasing productivity at the risk of an emerging zoonosis.

Germany is currently driven by certain factors, like the strict government regulations related to veterinary health and the high disposable income of the German people causing increased interest in the farm animals and companion animals. The government made vaccination mandatory for farm animals. This government mandate has a great impact on the market studied in Germany, as the country has a huge number of farm animals. Increasing awareness among the German population about the significance of both companion and farm animals’ health is the factor responsible for the growth of farm animal healthcare products segment, particularly anti-infective agents, parasiticides, and medicinal feed additives.

Scope of the Report

As per the scope of the report, veterinary healthcare is comprised of the products that are used in the diagnosis and treatment of the diseases in animals.

By Product
By Therapeutics
Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animals

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccine is Expected to Hold a Significant Share in the Therapeutics Segment Over the Forecast Period

In Germany, animal health is safeguarded by legislation and veterinary administration. Consequently, there has been an increase in the number of cases of antimicrobial resistance, in Germany. According to the German Medicinal Products Act, antibiotic vaccinations must be used in the treatment of diseased animals, and never as a growth promoter. Europe based company, Nordvacc produces vaccines that include Cunivak JET vaccines against myxomatosis in rabbits, and Febrivac PBE (triple vaccines against virus enteritis, botulism, and contagious pneumonia in mink). Hence, owing to these factors, along with rising pet ownership is expected to fuel the market growth over the forecast period.

To understand key trends, Download Sample Report

Competitive Landscape

The Germany Veterinary Healthcare market is moderately competitive and consists of a number of major players. Companies like Boehringer Ingelheim International GmbH, Ceva Animal Health Inc, Elanco Animal Health, Idexx Laboratories, Merck & Co. Inc., Phibro Animal Health, Randox Laboratories, Ltd, Vetoquinol GmbH, Virbac SA, Zoetis, Inc, among others, hold the substantial market share in the Veterinary Healthcare market in Germany.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 4.2.2 Rising Awareness and Initiatives by the Government

      3. 4.2.3 Increasing Productivity at the Risk of Emerging Zoonosis

    3. 4.3 Market Restraints

      1. 4.3.1 Increasing Cost of Animal Testing and Veterinary Services

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. 5.1.1.1 Vaccines

        2. 5.1.1.2 Parasiticides

        3. 5.1.1.3 Anti-infectives

        4. 5.1.1.4 Medical Feed Additives

        5. 5.1.1.5 Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Immunodiagnostic Tests

        2. 5.1.2.2 Molecular Diagnostics

        3. 5.1.2.3 Diagnostic Imaging

        4. 5.1.2.4 Clinical Chemistry

        5. 5.1.2.5 Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Boehringer Ingelheim International GmbH

      2. 6.1.2 Ceva Animal Health

      3. 6.1.3 Elanco Animal Health

      4. 6.1.4 Idexx Laboratories

      5. 6.1.5 Merck & Co. Inc.

      6. 6.1.6 Phibro Animal Health

      7. 6.1.7 Vetoquinol

      8. 6.1.8 Virbac SA

      9. 6.1.9 Zoetis, Inc

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports